Summary
Vermillion Inc (Vermillion) is a developer of multi-marker and diagnostic tests that addresses unmet needs in gynecologic oncology and women’s health. The company’s OVA1 is a simple blood test, which measures the levels of proteins found in the blood and then uses a proprietary software to calculate a single score. Its research and development center develops and validates biomarkers and algorithms. Vermillion offers its services to hospital laboratories, clinical reference laboratories, and physician offices. The company also collaborates with other academic institutions in oncology, cardiology and women’s health. Vermillion is headquartered in Austin, Texas, the US.
Vermillion Inc (VRML) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Vermillion Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Vermillion Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Vermillion Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Vermillion Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Vermillion Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Vermillion Inc, Medical Equipment, Deal Details 11
Partnerships 11
Vermillion Enters into Licensing Agreement with Quest Diagnostics 11
Vermillion Enters Into Distribution Agreement With Pronto Diagnostics 11
Vermillion Signs Agreement With Quest Diagnostics 12
Equity Offering 13
Vermillion Plans to Raise up to USD6.8 in Public Offering of Shares 13
Vermillion Raises USD5.2 Million in Private Placement of Shares and Warrants 14
Vermillion Raises USD18.8 Million in Public Offering of Shares 15
Vermillion Raises USD10.5 Million in Private Placement of Shares and Warrants 16
Vermillion Completes Private Placement Of Shares US$18 Million Upon Exercise Of Warrants 17
Vermillion Completes Private Placement Of Shares For US$13.2 Million 18
Vermillion Completes Public Offering Of US$21.8 Million 19
Acquisition 21
Vermillion Completes Acquisition Of Correlogic Systems For US$0.4 Million 21
Vermillion Inc - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Financial Announcements 26
May 11, 2017: Vermillion Reports First Quarter 2017 Results 26
Mar 29, 2017: Vermillion Reports Fourth Quarter and Full Year 2016 Results 27
Nov 10, 2016: Vermillion Reports Third Quarter 2016 Results 29
Aug 10, 2016: Vermillion Reports Second Quarter 2016 Results 30
May 16, 2016: Vermillion Reports First Quarter 2016 Results 31
Corporate Communications 32
Nov 14, 2016: Vermillion appoints chief medical officer 32
May 16, 2016: Vermillion Reports Fourth Quarter and Full Year 2015 Results 33
Product News 34
Mar 21, 2016: Vermillion Announces FDA Clearance of Overa, Second Generation OVA1 Test 34
Feb 16, 2016: Vermillion Teams up With NASCAR Driver Martin Truex, Jr. and Partner Sherry Pollex, an Ovarian Cancer Thriver, to "Accelerate" the National Conversation about Ovarian Cancer and OVA1 35
Feb 09, 2016: Vermillion Lands America's Most Decorated Gymnast and Ovarian Cancer Survivor, Shannon Miller, for its OVA1 Awareness Team 36
Product Approvals 37
Mar 21, 2016: Vermillion Announces FDA Clearance of Overa, Second Generation OVA1 Test 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
Vermillion Inc, Medical Equipment, Key Facts, 2016 1
Vermillion Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Vermillion Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Vermillion Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Vermillion Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Vermillion Inc, Deals By Market, 2011 to YTD 2017 9
Vermillion Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Vermillion Enters into Licensing Agreement with Quest Diagnostics 11
Vermillion Enters Into Distribution Agreement With Pronto Diagnostics 11
Vermillion Signs Agreement With Quest Diagnostics 12
Vermillion Plans to Raise up to USD6.8 in Public Offering of Shares 13
Vermillion Raises USD5.2 Million in Private Placement of Shares and Warrants 14
Vermillion Raises USD18.8 Million in Public Offering of Shares 15
Vermillion Raises USD10.5 Million in Private Placement of Shares and Warrants 16
Vermillion Completes Private Placement Of Shares US$18 Million Upon Exercise Of Warrants 17
Vermillion Completes Private Placement Of Shares For US$13.2 Million 18
Vermillion Completes Public Offering Of US$21.8 Million 19
Vermillion Completes Acquisition Of Correlogic Systems For US$0.4 Million 21
Vermillion Inc, Key Competitors 22
Vermillion Inc, Key Employees 23
Vermillion Inc, Subsidiaries 24
List of Figures
Vermillion Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Vermillion Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Vermillion Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Vermillion Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Vermillion Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Vermillion Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Vermillion Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Vermillion Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
